CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth

References

• Sotgia F, Del Galdo F, Casimiro MC, Bonuccelli G, Mercier I, Whitaker-Menezes D, et al. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. Am J Pathol 2009; 174:746 - 61; http://dx.doi.org/10.2353/ajpath.2009.080658; PMID: 19234134
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 2009; 174:2023 - 34; http://dx.doi.org/10.2353/ajpath.2009.080873; PMID: 19411448
   PubMed Web of Science ®Google Scholar
• Sloan EK, Ciocca DR, Pouliot N, Natoli A, Restall C, Henderson MA, et al. Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol 2009; 174:2035 - 43; http://dx.doi.org/10.2353/ajpath.2009.080924; PMID: 19411449
   PubMed Web of Science ®Google Scholar
• Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009; 8:3984 - 4001; http://dx.doi.org/10.4161/cc.8.23.10238; PMID: 19923890
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010; 9:3256 - 76; http://dx.doi.org/10.4161/cc.9.16.12553; PMID: 20814239
   PubMed Web of Science ®Google Scholar
• Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: a transcriptional informatics analysis with validation. Cell Cycle 2010; 9:2201 - 19; http://dx.doi.org/10.4161/cc.9.11.11848; PMID: 20519932
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 2010; 9:2423 - 33; http://dx.doi.org/10.4161/cc.9.12.12048; PMID: 20562526
   PubMed Web of Science ®Google Scholar
• Chiavarina B, Whitaker-Menezes D, Migneco G, Martinez-Outschoorn UE, Pavlides S, Howell A, et al. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis. Cell Cycle 2010; 9:3534 - 51; http://dx.doi.org/10.4161/cc.9.17.12908; PMID: 20864819
   PubMed Web of Science ®Google Scholar
• Surmann-Schmitt C, Sasaki T, Hattori T, Eitzinger N, Schett G, von der Mark K, et al. The Wnt antagonist Wif-1 interacts with CTGF and inhibits CTGF activity. J Cell Physiol 2012; 227:2207 - 16; http://dx.doi.org/10.1002/jcp.22957; PMID: 21928342
   PubMed Web of Science ®Google Scholar
• Levine JH, Moses HL, Gold LI, Nanney LB. Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. Am J Pathol 1993; 143:368 - 80; PMID: 8342593
   PubMed Web of Science ®Google Scholar
• Peltonen J, Kähäri L, Jaakkola S, Kähäri VM, Varga J, Uitto J, et al. Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol 1990; 94:365 - 71; http://dx.doi.org/10.1111/1523-1747.ep12874491; PMID: 2307855
   PubMed Web of Science ®Google Scholar
• Smith EA, LeRoy EC. A possible role for transforming growth factor-beta in systemic sclerosis. J Invest Dermatol 1990; 95:Suppl 125S - 7S; http://dx.doi.org/10.1111/1523-1747.ep12874998; PMID: 2258629
   PubMedGoogle Scholar
• Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107:404 - 11; http://dx.doi.org/10.1111/1523-1747.ep12363389; PMID: 8751978
   PubMed Web of Science ®Google Scholar
• Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Transcriptional evidence for the “Reverse Warburg Effect” in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer’s disease, and “Neuron-Glia Metabolic Coupling”. Aging (Albany NY) 2010; 2:185 - 99; PMID: 20442453
   PubMedGoogle Scholar
• Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993; 327:125 - 30; http://dx.doi.org/10.1016/0014-5793(93)80155-N; PMID: 7687569
   PubMed Web of Science ®Google Scholar
• Friedrichsen S, Heuer H, Christ S, Winckler M, Brauer D, Bauer K, et al. CTGF expression during mouse embryonic development. Cell Tissue Res 2003; 312:175 - 88; PMID: 12712324
   PubMed Web of Science ®Google Scholar
• Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993; 4:637 - 45; PMID: 8374172
   PubMed Web of Science ®Google Scholar
• Babic AM, Chen CC, Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999; 19:2958 - 66; PMID: 10082563
   PubMed Web of Science ®Google Scholar
• Safadi FF, Xu J, Smock SL, Kanaan RA, Selim AH, Odgren PR, et al. Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol 2003; 196:51 - 62; http://dx.doi.org/10.1002/jcp.10319; PMID: 12767040
   PubMed Web of Science ®Google Scholar
• Leask A, Denton CP, Abraham DJ. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J Invest Dermatol 2004; 122:1 - 6; http://dx.doi.org/10.1046/j.0022-202X.2003.22133.x; PMID: 14962082
   PubMed Web of Science ®Google Scholar
• Wenger C, Ellenrieder V, Alber B, Lacher U, Menke A, Hameister H, et al. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene 1999; 18:1073 - 80; http://dx.doi.org/10.1038/sj.onc.1202395; PMID: 10023684
   PubMed Web of Science ®Google Scholar
• Kubo M, Kikuchi K, Nashiro K, Kakinuma T, Hayashi N, Nanko H, et al. Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br J Dermatol 1998; 139:192 - 7; http://dx.doi.org/10.1046/j.1365-2133.1998.02354.x; PMID: 9767231
   PubMed Web of Science ®Google Scholar
• Steffen CL, Ball-Mirth DK, Harding PA, Bhattacharyya N, Pillai S, Brigstock DR. Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. Growth Factors 1998; 15:199 - 213; http://dx.doi.org/10.3109/08977199809002117; PMID: 9570041
   PubMed Web of Science ®Google Scholar
• Yang DH, Kim HS, Wilson EM, Rosenfeld RG, Oh Y. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab 1998; 83:2593 - 6; http://dx.doi.org/10.1210/jc.83.7.2593; PMID: 9661651
   PubMed Web of Science ®Google Scholar
• Vorwerk P, Wex H, Hohmann B, Oh Y, Rosenfeld RG, Mittler U. CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL). Br J Cancer 2000; 83:756 - 60; http://dx.doi.org/10.1054/bjoc.2000.1364; PMID: 10952780
   PubMed Web of Science ®Google Scholar
• Barbolina MV, Adley BP, Kelly DL, Shepard J, Fought AJ, Scholtens D, et al. Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion. Int J Cancer 2009; 125:816 - 25; http://dx.doi.org/10.1002/ijc.24347; PMID: 19382180
   PubMed Web of Science ®Google Scholar
• Lin BR, Chang CC, Chen RJ, Jeng YM, Liang JT, Lee PH, et al. Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer. Clin Cancer Res 2011; 17:3077 - 88; http://dx.doi.org/10.1158/1078-0432.CCR-09-3256; PMID: 21558398
   PubMed Web of Science ®Google Scholar
• Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, et al. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 2012; 31:2401 - 11; http://dx.doi.org/10.1038/onc.2011.423; PMID: 21927029
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment. Cell Cycle 2010; 9:3515 - 33; http://dx.doi.org/10.4161/cc.9.17.12928; PMID: 20855962
   PubMed Web of Science ®Google Scholar
• Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008; 283:10892 - 903; http://dx.doi.org/10.1074/jbc.M800102200; PMID: 18281291
   PubMed Web of Science ®Google Scholar
• Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, et al. Ketones and lactate “fuel” tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010; 9:3506 - 14; http://dx.doi.org/10.4161/cc.9.17.12731; PMID: 20818174
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos A, Lin Z, Pavlides S, et al. Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle 2011; 10:1271 - 86; http://dx.doi.org/10.4161/cc.10.8.15330; PMID: 21512313
   PubMed Web of Science ®Google Scholar
• Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 2000; 275:25130 - 8; http://dx.doi.org/10.1074/jbc.M001914200; PMID: 10833514
   PubMed Web of Science ®Google Scholar
• Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996; 271:32529 - 37; http://dx.doi.org/10.1074/jbc.271.51.32529; PMID: 8955077
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 2011; 1813:1263 - 8; http://dx.doi.org/10.1016/j.bbamcr.2010.08.006; PMID: 20732359
   PubMed Web of Science ®Google Scholar
• Chen J, Xavier S, Moskowitz-Kassai E, Chen R, Lu CY, Sanduski K, et al. Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol 2012; 180:973 - 83; http://dx.doi.org/10.1016/j.ajpath.2011.11.033; PMID: 22234173
   PubMed Web of Science ®Google Scholar
• Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, et al. Autophagy mediates the mitotic senescence transition. Genes Dev 2009; 23:798 - 803; http://dx.doi.org/10.1101/gad.519709; PMID: 19279323
   PubMed Web of Science ®Google Scholar
• Phanish MK, Winn SK, Dockrell ME. Connective tissue growth factor-(CTGF, CCN2)–a marker, mediator and therapeutic target for renal fibrosis. Nephron, Exp Nephrol 2010; 114:e83 - 92; http://dx.doi.org/10.1159/000262316
   PubMed Web of Science ®Google Scholar
• Brigstock DR. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999; 20:189 - 206; http://dx.doi.org/10.1210/er.20.2.189; PMID: 10204117
   PubMed Web of Science ®Google Scholar
• Razani B, Zhang XL, Bitzer M, von Gersdorff G, Böttinger EP, Lisanti MP. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem 2001; 276:6727 - 38; http://dx.doi.org/10.1074/jbc.M008340200; PMID: 11102446
   PubMed Web of Science ®Google Scholar
• Del Galdo F, Lisanti MP, Jimenez SA. Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2008; 20:713 - 9; http://dx.doi.org/10.1097/BOR.0b013e3283103d27; PMID: 18949888
   PubMed Web of Science ®Google Scholar
• Del Galdo F, Sotgia F, de Almeida CJ, Jasmin JF, Musick M, Lisanti MP, et al. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum 2008; 58:2854 - 65; http://dx.doi.org/10.1002/art.23791; PMID: 18759267
   PubMed Web of Science ®Google Scholar
• Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, Mercier I, et al. Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis. Antioxid Redox Signal 2012; 16:1264 - 84; http://dx.doi.org/10.1089/ars.2011.4243; PMID: 21883043
   PubMed Web of Science ®Google Scholar
• Frazier KS, Grotendorst GR. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 1997; 29:153 - 61; http://dx.doi.org/10.1016/S1357-2725(96)00127-6; PMID: 9076950
   PubMed Web of Science ®Google Scholar
• Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 2001; 61:8917 - 23; PMID: 11751417
   PubMed Web of Science ®Google Scholar
• Chien W, O’Kelly J, Lu D, Leiter A, Sohn J, Yin D, et al. Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol 2011; 38:1741 - 7; PMID: 21455569
   PubMed Web of Science ®Google Scholar
• Lai D, Ho KC, Hao Y, Yang X. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res 2011; 71:2728 - 38; http://dx.doi.org/10.1158/0008-5472.CAN-10-2711; PMID: 21349946
   PubMed Web of Science ®Google Scholar
• Wang MY, Chen PS, Prakash E, Hsu HC, Huang HY, Lin MT, et al. Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. Cancer Res 2009; 69:3482 - 91; http://dx.doi.org/10.1158/0008-5472.CAN-08-2524; PMID: 19351859
   PubMed Web of Science ®Google Scholar
• Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 2004; 11:781 - 91; http://dx.doi.org/10.1677/erc.1.00825; PMID: 15613452
   PubMed Web of Science ®Google Scholar
• Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Lüscher TF, Fujii T. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 1999; 274:37461 - 6; http://dx.doi.org/10.1074/jbc.274.52.37461; PMID: 10601320
   PubMed Web of Science ®Google Scholar
• Nishida T, Kondo S, Maeda A, Kubota S, Lyons KM, Takigawa M. CCN family 2/connective tissue growth factor (CCN2/CTGF) regulates the expression of Vegf through Hif-1alpha expression in a chondrocytic cell line, HCS-2/8, under hypoxic condition. Bone 2009; 44:24 - 31; http://dx.doi.org/10.1016/j.bone.2008.08.125; PMID: 18835464
   PubMed Web of Science ®Google Scholar
• Lu T, Finkel T. Free radicals and senescence. Exp Cell Res 2008; 314:1918 - 22; http://dx.doi.org/10.1016/j.yexcr.2008.01.011; PMID: 18282568
   PubMed Web of Science ®Google Scholar
• Campisi J. Cancer, aging and cellular senescence. In Vivo 2000; 14:183 - 8; PMID: 10757076
   PubMed Web of Science ®Google Scholar
• Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc 1997; 45:482 - 8; PMID: 9100719
   PubMed Web of Science ®Google Scholar
• Smith JR, Pereira-Smith OM. Replicative senescence: implications for in vivo aging and tumor suppression. Science 1996; 273:63 - 7; http://dx.doi.org/10.1126/science.273.5271.63; PMID: 8658197
   PubMed Web of Science ®Google Scholar
• Campisi J. Replicative senescence: an old lives’ tale?. Cell 1996; 84:497 - 500; http://dx.doi.org/10.1016/S0092-8674(00)81023-5; PMID: 8598035
   PubMed Web of Science ®Google Scholar
• Rinehart CA, Torti VR. Aging and cancer: the role of stromal interactions with epithelial cells. Mol Carcinog 1997; 18:187 - 92; http://dx.doi.org/10.1002/(SICI)1098-2744(199704)18:4<187::AID-MC1>3.0.CO;2-B; PMID: 9142212
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Whitaker-Menezes D, Lin Z, Flomenberg N, Howell A, Pestell RG, et al. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle 2011; 10:1784 - 93; http://dx.doi.org/10.4161/cc.10.11.15674; PMID: 21566463
   PubMed Web of Science ®Google Scholar